MENLO PARK, Calif., July 27, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the second quarter ended June 30, 2016, on Wednesday, August 3, 2016, after the market close. Geron’s management will also host a conference call for analysts and investors on Wednesday, August 3, 2016, at 4:30 p.m. Eastern Time to discuss the company’s second quarter results and recent events.
Participants can access the conference call live via telephone by dialing 877-303-9139 (U.S.); 760-536-5195 (international). The conference ID is 50542873. If accessing the conference call by telephone, please dial in at least 10 minutes early to minimize any delay in joining the call. A live audio-only webcast is also available at http://edge.media-server.com/m/p/dmhjza72/lan/en. The audio webcast of the conference call will be available for replay approximately one hour following the live broadcast through September 2, 2016.
Geron is a clinical stage biopharmaceutical company focused on the collaborative development of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.